使用抗微生物与抗生素协同作用的优点和挑战,用于治疗多药耐药细菌
Regina Meneses Gonçalves1, Bruna Estéfani Dutra Monges1, Karen Garcia Nogueira Oshiro1
1S-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS 79117900, Brazil.
与抗生素相结合的抗微生物 (AMP) 是对抗多药耐药细菌 (MDR) 的有希望的策略. 本综述探讨了它们在打击MDR感染方面的协同潜力,挑战和人工智能驱动的未来.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 耐多药细菌 (MDR) 构成了全球健康的重大威胁.
- 抗生素单一治疗在治疗MDR细菌感染方面面临挑战.
- 对抗MDR细菌有效的新型抗微生物药物的急需存在.
研究的目的:
- 审查抗微生物 (AMP) 与常规抗生素的协同使用.
- 分析AMP-抗生素联合治疗的优点和弱点.
- 讨论临床翻译挑战和人工智能 (AI) 应用.
主要方法:
- 对AMP与抗生素组合的体外和体内研究的文献综述.
- 对协同疗法的关键参数的分析.
- 探索用于预测有效组合的AI策略.
主要成果:
- AMP显示有选择性和有效的抗菌作用,耐受性良好.
- 与AMP和抗生素的联合治疗提供了一个可行的替代策略.
- 在体外和体外模型展示了协同方法的潜力.
结论:
- AMP-抗生素组合为MDR细菌提供了一个有希望的治疗途径.
- 需要进一步的研究来克服临床翻译的挑战.
- 人工智能具有优化和发现新型协同抗菌疗法的潜力.
更多相关视频
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
